Neuralynx, Inc. and Nihon Kohden

Bridging the Gap between Clinical and Research Electrophysiology


Neuralynx, Inc., a worldwide leader in research microwire electrophysiology, has expanded its global clinical research presence by partnering with Nihon Kohden Corporation, Japan's leading manufacturer, developer and distributor of medical electronic equipment with subsidiaries in the USA, Europe and Asia, and distributors in nearly every country in the world.

By linking the Neuralynx ATLAS Neurophysiology System with the Nihon Kohden JE-120A high-density EEG amplifier, users may now simultaneously record up to 256 channels for both clinical EEG and human single neuron research applications - at independent sample frequencies up to 10 kHz clinically and 40 kHz for research with independent data streams in a variety of data file formats. Easy access to connect/disconnect the ATLAS research system ensures continuous clinical data collection without interruption.

"The integration of cutting-edge research capabilities into clinical practice opens the door to advances in neurology and cognitive science. The research/clinical gap is bridged without compromise to clinical best practices," said Casey Stengel, President and Founder of Neuralynx.

"The partnership between Neuralynx and Nihon Kohden brings to light our mutual mission of the advancement of neurological science and moving that advancement to clinical reality. Allowing our customers to harness the power of Nihon Kohden innovation and Neuralynx top line research experience with integrated solutions paves the way for the future of neurodiagnostics," states Yasuhiro Yoshitake, General Manager International Operations Nihon Kohden Corporation.

December, 2014

Neuralynx announces partnership agreement with Nihon Kohden America.

August, 2015

Neuralynx announces partnership agreement with Nihon Kohden Corporation.

About Nihon Kohden

Nihon Kohden is a worldwide market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation. Nihon Kohden’s major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, and hematology analyzers. Nihon Kohden equipment is well known for its quality and ease of use.


Nihon Kohden’s long legacy in EEG diagnostics and monitoring continues with the EEG-1200, which combines EEG, long-term epilepsy, cEEG ICU monitoring and sleep testing for the most flexible and comprehensive recording system available today. More information about Nihon Kohden and EEG-1200 technology can be found at www.nihonkohden.com


Nihon Kohden America was founded in 1979 as a wholly-owned subsidiary of Nihon Kohden Corporation, Japan. www.nkusa.com


As the adoption of academic research into clinical practice accelerates, Nihon Kohden and Neuralynx are bridging the research-to-clinical gap to improve epilepsy treatment and research outcomes. Monitoring seizures with the fine sampling resolution of our systems can aid in the analysis and better understanding of the mechanisms of seizure generation to determine treatment plans and ultimately improve patient outcomes.
- Kathy Hart, Vice President of Marketing, Nihon Kohden America

www.nkusa.com www.nihonkohden.com NK logo

Bridging the Gap between Clinical and Research Electrophysiology